3Nived O, Sturfelt G, Liang MH, et al. The ACR nomenclature for CNS lupus revisited. Lupus, 2003, 12: 872-876.
4Afeltra A, Amoroso A, Mitterhofer AP, et al. The 677C→T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus.Seizure, 2002, 11: 250-254.
5Rudolf P Jr, Skerenova M, Hybenova J, et al. Apolipoprotein E polymorphism in patients with neuropsychiatric SLE. Clin Rheumatology, 2004, 23: 97-101.
6Benyahia B, Amoura Z, Rousseau A, et al. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases. J Neurooncol, 2003, 62: 349-351.
7Weiner SM, Klein R, Berg PA. A longitudinal study of auto-antibodies against central nervous system tissue and gangliosides in connective tissue diseases. Rheumatol Int, 2000, 19: 83-88.
8Sastre-Garriga J, Montalban X. APS and the brain. Lupus, 2003,12: 877-882.
9彭斌 李舜伟 蒋明 David YU 林孝义 等主编.风湿病的神经系统表现[A].蒋明,David YU,林孝义,等主编.中华风湿病学[C].北京:华夏出版社,2004.630-631,640.
10Silva LM, Garcia AB, Donadi EA. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations. J Neurol, 2002, 249: 1048-1054.
2Stojanovich L, Stojanovich R,Kostich V,et al.Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone(pilot study).Lupus,2003,12:3-7.
3Sanna G,Khamaashta MA,Sanni G.Low-dose pulse cyclophos-phamide in the treatment of neuropsychiatric lupus. Lupus,2003,12:1-2.
4Neuwelt CM,Lacks S,Kaye BR,et al. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med,1995,98:32-41.
5Boumpas DT,Yamada H,Patronas NJ,et al. Pulse cyclophosphamide for severe neuropyschiatric lupus. Q J Med, 1991,81:975-984.
6Sterling GW.Neuropsychiatric lupus. Rheum Dis Clin North Am,1994,20:129-158.
7Anon.The Amercian College of Rheumatology nomenclature and case definitions for neurpsychiatric lupus syndromes. Arthritis Rheum, 1999,42:599-608.
8Sabbadini MG,Manfredi AA,Bozzolo E,et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus,1999,8:9-11.
9Stimmler MM,Coletti PM,Quismorio FP Jr. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum,1993,22:335-349.
10McCune WJ,MacGuire A,Gebarski S.Identification of brain lesions in neuropsychiatric lupus erythematosus. Neurology, 1990,29:460-464
3Afeltra A,Amoroso A,Mitterhofer AP,et al.The 677C→T mutation in the methylene tetrahydrofolate reduetase (MTHFR) gene in epileptie patients affected by systemic lupus erythematosus.Seizure,2002,11:250-254.
4Rudolf P Jr,Skerenova M,Hybenova J,et al.Apolipoprotein E,polymorphism in patients with neuropsychiatric SLE.Clin Rheumatology.2004,23:97-101.
5Weiner SM,Klein R,Berg PA.A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases.Rheumatol Int.2000,19:83-88.
6Williams R C J,Sugiura K,Tan E M.Antibodies to microtubuleassociated protein 2 in patients with neuropsychiatric systemic lupus erythematosus[J].Arthritis Rheum,2004,50(4):1239.
7Benyahia B,Amoura Z,Rousseau A,et al.Paraneoplastitantineuronal antibodies in patients with systemic autoimmune diseases.J Neurooneol,2003,62:349-35l.
8De Giorgio LA,Konstantinov KN,Lee SC,et al.A subset of lupus anti DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus.Nat Med,2001,7:1189-1193.
9Kowal C,de Giorgio LA,Nakaoka T,et al.Cognition and Immunity antibody impairs memory.Immunity,2004,21:l79-188.
10Suarezluis I,Rodriguez Y,RoussoViota T,et al.Some considerations about the possible pathological mechanisms at work in antiphospholipid syndrome and stroke[J].Rev Neurol,2003,37(7):654-657.
